TG and neoplasm: However, despite these TgAb effects, a rising Tg RIA trend was seen for patients with progressive DMD (Fig. 3) concomitant with a rising TgAb trend—the latter increasingly being recognized as a surrogate DTC tumor marker (3, 4, 42, 43).